Calgary Information Day 2012

Join us for a day of Hope and Support

Event Details

Speakers and Presentations

Keynote Speaker: Dr. Gregory Cairncross

Additional Presentation Topics:

• Quality of Life
• Pediatric Brain Tumours
• Non Malignant Brain Tumours

Dr Gregory Cairncross Biography

Dr. Gregory Cairncross is Professor and Head of the Department of Clinical Neurosciences at the University of Calgary. He is also the holder and first recipient of the Alberta Cancer Foundation Chair in Brain Tumor Research.

Dr Cairncross is best known for his research contributions to the field of neuro-oncology. In 1988, he and Dr David Macdonald discovered that oligodendrogliomas, a type of brain cancer, are sensitive to chemotherapy. A decade later, he and Dr David Louis discovered a molecular marker of chemosensitivity and long survival in this type of brain cancer. Testing for allelic loss of chromosomes 1p and 19q is now used worldwide to assist in the diagnosis and care of patients with oligodendrogliomas. This discovery has also provided a new framework for basic research in neuro-oncology and brain tumor clinical trials.

Dr Cairncross has published extensively on brain tumor biology and therapy, writings which have been cited over 6,000 times. He is the past recipient of many research awards from North America and Europe. In 2007, he was appointed Director of the Clark H. Smith Brain Tumor Centre at the University of Calgary.

His current research interests include the detection of genetic signatures in gliomas using magnetic resonance imaging (MRI) and the identification of clinically relevant molecular markers in glial tumors.
 

To learn more about Information Days please contact:

Sue Ruypers
Research and Education Specialist
sruypers@braintumour.ca
1-800-265-5106 or 519-642-7755 ext 240